FMR LLC 13D and 13G filings for PTC Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-10 08:53 am Sale | 2024-01-09 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 1,814,421 2.404% | -4,617,429 (-71.79%) | Filing |
| 2023-11-13 09:02 am Sale | 2023-11-10 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 6,431,850 8.523% | -4,350,456 (-40.35%) | Filing |
| 2023-02-09 12:31 pm Purchase | 2023-02-09 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 10,782,306 14.999% | 177,621 (+1.67%) | Filing |
| 2022-02-09 10:24 am Purchase | 2022-02-08 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 10,604,685 15.000% | 365,530 (+3.57%) | Filing |
| 2021-02-08 10:31 am Purchase | 2021-02-05 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 10,239,155 14.999% | 3,519,111 (+52.37%) | Filing |
| 2020-07-10 11:38 am Purchase | 2020-07-09 | 13G | PTC Therapeutics, Inc. PTCT | FMR LLC | 6,720,044 10.541% | 4,271,902 (+174.50%) | Filing |